References
Abildgaard U.: Antithrombin and related inhibitors of coagulation. InPoller L. (Ed.): Recent advances in blood coagulation. Churchill and Livingstone, Edinburgh-London-Melbourne-New York, 1981; p. 151.
Barbui T., Rodeghiero F.: Hereditary dysfunctional antithrombin III (AT-III Vicenza)—Thrombos. Haemost.15, 97, 1981.
Boyer C., Tripodi A., Wolf M., Mannucci P. M., Larrieu M. J.: A new familial variant of antithrombin III: ‘antithrombin III Milano’—Thrombos. Haemost.50, 51, 1983. (Abstract).
Collen D., Schetz J., DeCock F., Holmer E., Verstraete M.: Metabolism of antithrombin III (heparin cofactor) in man effects of venous thrombosis and of heparin administration—Europ. J. clin. Invest.7, 27, 1977.
Egeberg O.: Inherited antithrombin deficiency causing thrombophilia—Thrombos. Diathes. haemorrh. (Stuttg.)13, 516, 1955.
Gomperts E. D., Feesay M., van der Walt J. D.: Two-dimensional electrophoretic studies in antithrombin III deficiency—Thrombos. Res.8, 713, 1976.
Lake A. M., Stauffer J. A., Syuart M. J.: Hemostatic alterations in inflammatory bowel diseases response to therapy—Amer. J. dig. Dis.23, 897, 1978.
Mannucci L., Dioguardi N., Del Ninno E., Mannucci P. M.: Value of Normotest and antithrombin III in the assessment of liver function—Scand. J. Gastroenterol.8 (Suppl. 19), 103, 1973.
Mannucci P. M., Boyer C., Wolf M., Tripodi A., Larrieu M. J.: Treatment of congenital antithrombin III deficiency with concentrates—Brit. J. Haematol.50, 531, 1982.
Marciniak E., Farley C. H., De Simone P. A.: Familial thrombosis due to antithrombin III deficiency—Blood43, 219, 1974.
Marciniak E., Gockerman J. P.: Heparin-induced decrease in circulating antithrombin III—Lancetii, 581, 1977.
Matsuo T., Ohki Y., Kondo S., Matsuo O.: Familial antithrombin III deficiency in a Japanese family—Thrombos. Res.16, 815, 1979.
Murayama H., Matsuda M.:: Abnormal antithrombin III with defective biological and immunological functions found in a thrombophilic patient. ‘Antithrombin III Tokyo’—Thombos. Haemost.50, 358, 1983.
Nagy I., Losonczy H., Hergert K., Szilágyi C.: Durch hereditäre Antithrombin III Vermin derung verursachte rezidivierende Thromboembolien bei Jagendlichen—Folia haematol. (Lpz.)102, 233, 1975.
Nagy I., Losonczy H., Szaksz I., Temesi C., Hergert K.: An analysis of clinical and laboratory data in patients with congenital antithrombin. III (AT-III) deficiency—Acta med. Acad. Sci. hung.36, 53, 1979.
Penner J. A., Hassouna H., Hunter M. J., Chockley M. A.: A clinically silent antithrombin III defect in an Ann Arbor family—Thrombos. Haemost.42, 186, 1979. (Abstract).
Pitney W. R., Phadke K. P., Dean S.: Antithrombin III deficiency during asparaginase therapy— Lanceti, 493, 1980.
Rák K.: Attempt to better assess the haemostatic functions in patients with chronic liver diseases—Thrombos. Haemost.50, 273, 1983. (Abstract).
Sakuragawa N., Takahashi T., Horikoshi I.: Congenital abnormal antithrombin III—Thrombos. Haemost.46, 285, 1981. (Abstract).
Sas G., Blaskó G., Bánhegyi D., Jákó J., Pálos L. A.: Abnormal antithrombin III (antithrombin III ‘Budapest’) as a cause of a familial thrombophilia—Thrombos. Diathes. haemorrh. (Stuttg.)32, 105, 1974.
Sas G., Pepper D. S., Cash J. D.: Investigations on antithrombin III in normal plasma and serum—Brit. J. Haematol.30, 265, 1975.
Sas G., Pető I., Bánhecyi D., Blaskó G., Domján G.: Heterogeneity of the ‘classical’ antithrombin III deficiency—Thrombos. Haemost.43, 133, 1980.
Shapiro S. S., Prager D. D., Martinez J.: Inherited antithrombia III deficiency associated with multiple thromboembolic phenomena—Blood42, 1001, 1973. (Abstract).
Sørensen P. J., Dyerberg J., Stoffersen E., Krogh Jensen M.: Familial functional antithrombin III deficiency—Scand. J. Haematol.24, 105, 1980.
Sørensen P. J., Sas G., Pető I., Blaskó G., Kremmer T., Samu A.: Distinction of two pathological antithrombin III molecules: antithrombin ‘Aalborg’ and antithrombin III ‘Budapest’—Thrombos. Res.26, 211, 1982.
Tengborn L., Frohm B., Nilsson L. E., Nilsson I. M.: Antithrombin III concentrate: its catabolism in health and in antithrombin III deficiency—Scand. J. clin. Lab. Invest.41, 469, 1981.
Thaler E., Lechner K.: Antithrombin III deficiency and thromboembolism—Clin. Haematol.10, 369, 1981.
Tran T. H., Boonameaux H., Bondeli C., Honkanen H., Marbet G. A., Duckert F.: Purification and partial characterzation of a hereditary abnormal antithrombin III fraction of a patient with recurrent thrombophlebitis—Thrombos. Haemost.44, 87, 1980.
van der Meer J., Stoepman van Dalen E. A., Jansen J. M. S.: Antithrombin III deficiency in a Dutch family—J. clin. Pathol.26, 532, 1973.
Wolf M., Boyer C., Laverone J. M., Larrieu M. J.: A new familial variant of antithrombin III: ‘antithrombin III Paris’—Brit. J. Haematol.51, 285, 1982.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sas, G. Congenital and acquired defects of antithrombin III. La Ricerca Clin. Lab. 14, 491–497 (1984). https://doi.org/10.1007/BF02904876
Issue Date:
DOI: https://doi.org/10.1007/BF02904876